{"transactions":[{"id":754238,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-06-02T20:16:04.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests annually as to 1/4th of the total award, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vested on June 2, 2026."}],"balance_after":7500,"derivative":{"expiration_date":"2029-06-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001761333-26-000005","document":"form4-06022026_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133326000005/form4-06022026_080600.xml","form_type":"4"}},{"id":754237,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-02T20:16:04.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"For avoidance of doubt, the reporting person elected to satisfy tax withholding liabilities in cash in lieu of withholding shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported total includes 250 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its employee stock purchase plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c)."}],"balance_after":4725,"source":{"system":"sec-edgar","filing":"0001761333-26-000005","document":"form4-06022026_080600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133326000005/form4-06022026_080600.xml","form_type":"4"}},{"id":865704,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-03T23:51:52.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date."}],"balance_after":5000,"derivative":{"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001761333-26-000002","document":"form4-03032026_110348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133326000002/form4-03032026_110348.xml","form_type":"4"}},{"id":865703,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:51:52.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026."}],"balance_after":40000,"derivative":{"exercise_price":20.55,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001761333-26-000002","document":"form4-03032026_110348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133326000002/form4-03032026_110348.xml","form_type":"4"}},{"id":957981,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-29T21:47:42.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total option award shall vest monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026."}],"balance_after":8200,"derivative":{"exercise_price":10.38,"expiration_date":"2035-12-23","underlying":"Common Stock","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001761333-25-000008","document":"form4-12292025_091238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133325000008/form4-12292025_091238.xml","form_type":"4"}},{"id":1017459,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-10-16T12:18:45.000Z","date":"2025-10-15","kind":"purchase","planned":false,"acquired":true,"shares":19750,"price":0.81,"value":15997.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8099 to $0.8100, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":19750,"source":{"system":"sec-edgar","filing":"0001761333-25-000005","document":"form4-10162025_121041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000176133325000005/form4-10162025_121041.xml","form_type":"4"}},{"id":1127304,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-06-02T20:27:52.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vests annually as to 1/4th of the total award beginning on June 2, 2026, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"expiration_date":"2029-06-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-015142","document":"form4-06022025_080648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000141588925015142/form4-06022025_080648.xml","form_type":"4"}},{"id":1127303,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:27:52.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option award vests on June 2, 2026.  The remainder vests ratably as to 1/48th of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":275000,"derivative":{"exercise_price":0.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001415889-25-015142","document":"form4-06022025_080648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1382101/000141588925015142/form4-06022025_080648.xml","form_type":"4"}},{"id":2917338,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-06T22:02:09.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":343000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 4, 2021.  One-half of the options vest on January 4, 2022.  The remaining one-half of the options vest as follows:  1/3 on January 4, 2023; 1/3 on January 4, 2024; and 1/3 on January 4, 2025."}],"balance_after":343000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-01-04","underlying":"Common Shares","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001567619-21-000611","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921000611/doc1.xml","form_type":"4"}},{"id":3085252,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Shares","published_at":"2020-07-10T22:57:10.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":126668,"price":6.05,"value":766341.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 225,000 restricted stock units, previously reported on a Form 4/A filed with the Securities and Exchange Commission on March 10, 2020."}],"balance_after":232846,"source":{"system":"sec-edgar","filing":"0001567619-20-013189","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920013189/doc1.xml","form_type":"4"}},{"id":3158694,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Shares","published_at":"2020-05-07T21:15:29.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units previously granted with original vesting date of June 10, 2020, shall now vest on July 10, 2020."}],"balance_after":359514,"source":{"system":"sec-edgar","filing":"0001567619-20-009229","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920009229/doc1.xml","form_type":"4/A","original_submission_date":"2020-03-12"}},{"id":3214409,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Common Shares","published_at":"2020-03-12T20:37:28.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units which shall vest on June 10, 2020."}],"balance_after":359514,"source":{"system":"sec-edgar","filing":"0001567619-20-006195","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920006195/doc1.xml","form_type":"4"}},{"id":3295585,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & CFO"}}],"security":"Employee Option Grant","published_at":"2020-02-04T02:41:10.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on 1/31/2021; the remaining 50% vest as follows:  1/3 on 1/31/2022; 1/3 on 1/31/2023; and 1/3 on 1/31/2024."}],"balance_after":1200000,"derivative":{"exercise_price":6.91,"expiration_date":"2030-01-30","underlying":"Common Shares","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001567619-20-001978","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920001978/doc1.xml","form_type":"4"}},{"id":3497907,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CFO"}}],"security":"Common Shares","published_at":"2019-06-07T18:03:02.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":7500,"price":1.842,"value":13815.0,"ownership":{"direct":true},"balance_after":134514,"source":{"system":"sec-edgar","filing":"0001567619-19-013037","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919013037/doc1.xml","form_type":"4"}},{"id":3596293,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CFO"}}],"security":"Common Shares","published_at":"2019-03-14T21:32:59.000Z","date":"2019-03-13","kind":"purchase","acquired":true,"shares":5000,"price":1.7856,"value":8928.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.779 to $1.79, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":127014,"source":{"system":"sec-edgar","filing":"0001567619-19-006894","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919006894/doc1.xml","form_type":"4"}},{"id":3596292,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CFO"}}],"security":"Common Shares","published_at":"2019-03-14T21:32:59.000Z","date":"2019-03-13","kind":"purchase","acquired":true,"shares":10000,"price":1.7394,"value":17394.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.735 to $1.74, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":122014,"source":{"system":"sec-edgar","filing":"0001567619-19-006894","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919006894/doc1.xml","form_type":"4"}},{"id":3710950,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":42319,"kind":"person","name":"Chow Gregory K.","position":1,"cik":"0001761333","reported_name":"Chow Gregory K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-04T01:01:27.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  50% on the first anniversary of the grant with the remaining 50% to vest as follows:  1/3 on the second anniversary of the grant; 1/3 on the third anniversary of the grant; and 1/3 on the fourth anniversary of the grant."}],"balance_after":300000,"derivative":{"exercise_price":1.91,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567619-19-000417","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919000417/doc1.xml","form_type":"4"}}]}